---
schema_version: "secwatch.filing_event.v1"
accession: "0001356576-23-000056"
form_type: "8-K"
ticker: "SUPN"
cik: "0001356576"
company_name: "SUPERNUS PHARMACEUTICALS, INC."
filed_at: "2023-08-21T23:59:59+00:00"
generated_at: "2026-06-11T06:03:10.123001+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Supernus appoints Bethany L. Sensenig to Board of Directors

## Summary
- Ms. Sensenig appointed as independent director and Audit Committee member effective August 17, 2023.
- 2023 compensation: $62,500 prorated for service plus options to buy 24,153 shares at $30.22 (4-year vest).
- Board expands to seven members; Ms. Sensenig brings 20+ years pharma/biotech financial leadership.
- Former CFO/Interim CEO of 9 Meters Biopharma and VP Finance & Commercial Ops at Biogen.

## SEC filing metadata
- accession: 0001356576-23-000056
- form_type: 8-K
- ticker: SUPN
- cik: 0001356576
- company_name: SUPERNUS PHARMACEUTICALS, INC.
- filed_at: 2023-08-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1356576/000135657623000056/0001356576-23-000056-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1356576/000135657623000056/supn-20230817.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001356576-23-000056
- JSON: https://secwatch.observer/filing/0001356576-23-000056.json
- Plain text: https://secwatch.observer/filing/0001356576-23-000056.txt

## Key facts
- Executive change
  Bethany L. Sensenig was appointed as member of the Board of Directors at SUPERNUS PHARMACEUTICALS, INC..
  - Action: appointed
  - Role: member of the Board of Directors
  source text: As of August 17, 2023, the Board of Directors of Supernus Pharmaceuticals, Inc. (the “Company”) appointed Bethany L. Sensenig as a member of the Board of Directors of the Company and as a member of the Audit Committee.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1356576/000135657623000056/0001356576-23-000056-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.